News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

e-Therapeutics plc' ETS2101 Enters Phase I Clinical Trial in Brain Cancer


6/19/2012 10:48:51 AM

OXFORD & NEWCASTLE, England & SAN DIEGO--(BUSINESS WIRE)--e-Therapeutics plc (AIM: ETX) announces the start of the first clinical trial evaluating its compound ETS2101 as a treatment for cancer. The phase I trial is enrolling patients with primary brain cancer (glioma) or cancer that has spread to the brain from other sites.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES